Purpose: The aim of this study was to investigate the effect of dexmedetomidine (DEX) continuous infusion on blood flow in rabbit oral tissues during sevoflurane or propofol anesthesia. 
Introduction
Bleeding during surgery should be minimized to avoid blood transfusion and to promote rapid recovery after surgery. In oral and maxillofacial surgery, control of bleeding is also important to establish a clear surgical field because oral mucosa and bone marrow consist of abundant vessels. 1 Therefore, several studies have been conducted on the control of oral tissue blood flow during general anesthesia.
There have been a number of studies on the control of tissue blood flow using deliberate hypotension, [2] [3] [4] [5] and its usefulness is indicated. However, because complications of deliberate hypotension such as brain damage are also reported, [6] [7] safer strategies to control tissue blood flow has been investigated. We have studied the changes in oral tissue blood flow during general anesthesia [8] [9] [10] [11] and reported that remifentanil decreased tongue mucosal blood flow (TBF), mandibular bone marrow blood flow (BBF), masseter muscle blood flow (MBF) and alveolar tissue blood flow in a dose-dependent manner. 12 Recent studies report an infusion of dexmedetomidine (DEX), a highly selective α2 agonist, [13] [14] [15] decreased bleeding during surgery. [16] [17] [18] Durmus et al. 16 and 4 Ayoglu et al. 17 reported that DEX decreased bleeding during tympanoplasty and septorhinoplasty. Richa et al. 18 reported that DEX decreased bleeding during maxillofacial surgery. These reports suggest that DEX may decrease tissue blood flow of the surgical field. Durmus et al. 16 reported that the effect of DEX on systemic circulation was slight and thus bleeding might be reduced by the peripheral vasoconstrictive effect of DEX. It is reported that α2B receptor-mediated vasoconstriction by DEX decreased blood flow in the brain 19-21 and forearm. 22 Meanwhile, Richa et al. 18 reported that DEX decreased tissue blood flow through its hypotensive effects caused by an inhibition of sympathetic nervous activities. Another study reported that nutrient organ blood flow decreased through the reduction in oxygen consumption by the organs. 23 Thus, the mechanism whereby DEX decreases tissue blood flow is still unclear. In addition, there are as yet no reports concerning the effect of DEX on the blood flow in oral tissues.
In this study, therefore, we investigated the effect of DEX on systemic circulation and blood flow in the oral tissues in rabbits. We discussed the mechanisms whereby DEX decreases blood flow in the oral tissues.
Methods
Twenty-four male Japan White rabbits weighing approximately 2.5 kg were used in this study. This study was approved by the Animal Research Ethics Committee at Tokyo Dental College (NO. 232502). All animals received humane care in accordance with the Guideline for the Treatment of Experimental Animals approved by Tokyo Dental College, Chiba, Japan.
Anesthesia was induced with 3.0% isoflurane (Forane, Abbott Japan, Tokyo, Japan). Tracheotomy was performed using infiltration anesthesia with 0. An initial loading dose of 6.0 μg･kg -1 ･hr -1 DEX was administered over 10 minutes.
DEX was then maintained at 0.2, 0.4 and 0.6 μg･kg -1 ･hr -1 , respectively, in this order.
Each infusion was maintained for 1 hour. Variables were observed at the end of each infusion.
To confirm the recovery of systemic hemodynamic variables and tissue blood flow after the completion of DEX administration, DEX was infused at 0.6 μg･kg -1 ･hr Values are expressed as the mean ± standard deviation. One-way ANOVA for repeated measurements followed by Dunnett test were used for intra-group comparisons. The Student t-test for unpaired samples was used for inter-group comparisons. A p value less than 0.05 were considered statistically significant.
Results (Tables 1, 2 HR, SBP and MAP were decreased in a dose-dependent manner during DEX infusion in both S and P groups. HR was decreased by 10-16%, SBP was decreased by 5-12%
and MAP was decreased by 5-10% in both groups. DBP was decreased by 6% during DEX infusion at 0.6 μg･kg -1 ･hr -1 in P group.
CCBF was decreased in a dose-dependent manner during dexmedetomidine infusion in both groups. CCBF was decreased by 13-19% in S group and by 10-16% in P group. CCBF at 0.6 μg･kg -1 ･hr -1 of DEX infusion in S group was smaller than that in P group.
Oral tissue blood flows (TBF, BBF, MBF, UBF, LBF) were decreased in a dose-dependent manner during DEX infusion in both groups. TBF was decreased by 13-25% in S group and by 15-31% in P group. TBF at 0.2 μg･kg -1 ･hr -1 of DEX infusion in S group was smaller than that in P group. BBF was decreased by 12-25% in S group and by 14-31% in P group. MBF was decreased by 11-32% in S group and by 17-35% in P group. UBF was decreased by 15-36% in S group and by 21-39% in P group. LBF was decreased by 12-35% in S group and by 13-34% in P group.
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The vascular resistances of the oral tissues were increased in a dose-dependent manner during DEX infusion in both groups. TVR was increased by 18-25% in S group and by 26-31% in P group. BVR was increased by 15-25% in S group and by 27-37% in P group. MVR was increased by 27-39% in S group and by 27-49% in P group. UVR was increased by 31-47% in S group and by 37-49% in P group. LVR was increased by 23-47% in S group and by 24-40% in P group. 
Discussion
This study showed that TBF, MBF, BBF, UBF, and LBF were decreased in a dose-dependent manner during DEX infusion in both S and P groups (30-40 % at 0.6 μg/kg/hr). Although HR, SBP, MAP, and CCBF were also decreased, these changes were smaller than those in oral tissue blood flow. The decreases in systemic hemodynamic variables and tissue blood flows were comparable between S and P groups. It is therefore suggested that DEX shows similar effects during sevoflurane or propofol anesthesia.
In this study, the dose or concentration to maintain basal anesthesia was the same as that in the report of Kemmochi et al. 11 These values are based on the blood concentration of propofol at Cp50 skin incision (plasma concentration at which 50% of patients do not respond to skin incision) and 0.5 minimum alveolar concentration (MAC) for sevoflurane in rabbits. [25] [26] [27] Terakawa et al. 28 reported that the adequate infusion rate of rocronium bromide which provide stable muscular relaxation was 14 μg･kg -1 ･min -1 during sevoflurane or propofol anesthesia. Therefore, this infusion rate was adopted in this study. To expose masseter muscle and periosteum of the mandibular body, skin incisions were performed without local anesthesia to prevent lidocaine-induced changes in tissue blood flow. These surgical procedures per se might influence tissue blood flow. However, these procedures were essential to precisely place the needle electrodes on the masseter muscle and periosteum of the mandibular body.
Putative mechanisms for decreased blood flow in oral tissues during DEX infusion are hypotension resulting from DEX-induced inhibition of sympathetic nervous activities or peripheral vasoconstriction by DEX. 29 Richa et al. 18 reported that bleeding during maxillofacial surgery was decreased by an initial loading dose of 0.1 μg･kg -1 ･min -1 followed by a continuous infusion at 0. In our study, DEX at the rate of more than 0.4 μg･kg -1 ･hr -1 increased vascular resistance in all oral tissues. The increase in the vascular resistance suggests that DEX may induce peripheral vasoconstriction caused by α2B receptor-medicated mechanisms, as in cerebral vessels. However, the relative increase in vascular resistance in the oral tissues was smaller than that in cerebral vessels when compared to the report of Ogawa et al. 24 , even at the same administration rate. In addition, there is no report investigating the distribution of α2B receptors in oral tissues. Therefore, vasoconstrictive effect cannot fully explain the blood flow decrease in these tissues.
Another possibility based on the dose-dependent decrease in MAP and CCBF is that DEX may have decreased cardiac output, thereby decreasing blood flow in the oral tissues. Bloor et al. 37 reported that cardiac output decreased in a dose-dependent manner when more than 0.5 μg･kg -1 DEX was administered, and the decrease was by approximately 41% at a dosage of 2 μg･kg -1 . Ebert et al. 38 and Dutta et al. 39 reported that DEX decreased cardiac output in a plasma concentration-dependent manner.
Lawrence et al. 23 also reported that DEX administered at 0.1, 1, or 10 μg･kg -1 to dogs under general anesthesia decreased cardiac output, MAP and nutrient organ blood flow in a concentration-dependent manner. In our study, CCBF showed a decrease by approximately 10-20% during DEX infusion. These findings suggest that α2B receptor-mediated vasoconstriction and α2A receptor-mediated sympathetic inhibition caused a decrease in cardiac output, and thus contributing to decreased tissue blood flow.
In our study, the effect of DEX on blood pressure was relatively small, and blood flow in oral tissues was found to decrease significantly. DEX has been used primarily in an ICU situation for sedation. 13, 29 However, DEX has many other useful actions, including an α2A receptor-mediated analgesic effect even under general anesthesia 13 , and a MAC-lowering effect 40 due to sympathetic inhibition and a reduction of catecholamine release. These facts suggest that DEX may be a useful agent in general anesthesia for oral surgical procedures.
In conclusion, DEX decreased TBF, MBF, BBF, UBF, and LBF in a dose-dependent manner both under sevoflurane and propofol anesthesia. These decreases may be attributable to α2B receptor-mediated peripheral vasoconstriction and cardiac output reduction through α2A receptor-mediated sympathetic inhibition. Data are expressed as mean ± SD, n=9. Data are expressed as mean ± SD, n=9.
